DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Harvard Division of Continuing Education
  3. DCE Theses and Dissertations
  4. Identifying Non-canonical, Keap1-independent Regulators of Nrf2 Degradation in Non-small Cell Lung Cancer

Identifying Non-canonical, Keap1-independent Regulators of Nrf2 Degradation in Non-small Cell Lung Cancer

Open/View files
LKB thesis final submission for grading.pdf (1.54 MB)
Date
December 21, 2022
Author(s)
Brodeur, Lauren K.
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Brodeur, Lauren K. 2022. Identifying Non-canonical, Keap1-independent Regulators of Nrf2 Degradation in Non-small Cell Lung Cancer. Master's thesis, Harvard University Division of Continuing Education.
Abstract
Nrf2 (nuclear factor erythroid 2-related factor 2) is a transcription factor responsible for cellular antioxidant response to oxidative and electrophilic stress. Keap1 (Kelch ECH associating protein 1) has been demonstrated to promote the proteasomal degradation of Nrf2 by functioning as a substrate adaptor protein for the E3 ligase Cul 3 (Cullin 3). However, recent evidence suggests that additional factors are at play in the regulation of Nrf2. Predictably, inhibition of Keap1 results in the stabilization of Nrf2. However, Nrf2 is still rapidly degraded after Keap1 knockout or inhibition. The persistently short Nrf2 half-life in the absence of Keap1 provides strong evidence that Keap1 is not the only negative regulator of Nrf2. Thus, with the aim of identifying novel regulators of Nrf2, a siRNA screen targeting members of the ubiquitome was performed using a luciferase complementation assay. The screen identified known complex members involved in Cul3-mediated degradation of Nrf2, as well as novel hits. Data mining and follow up efforts proposed six potential novel Nrf2 regulators. Further validation revealed Sart1/Vhl as strong candidates for Nrf2 regulation; knockdown of Sart1/Vhl activated a Nrf2-MafK luciferase complementation assay, indicating stabilization of Nrf2. Sart1/Vhl knockdown also demonstrated activity in Nrf2 transcriptional target reporters, SRXN1, OSGIN1 and antioxidant response elements (ARE). Sart1/Vhl are documented Hif-1α regulators; more studies are needed to elucidate the mechanism of action, and the potential role of Hif-1α in Nrf2 regulation.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37373927
Subjects

Hif-1a

Keap1

lung cancer

Nrf2

Sart1

Vhl

Oncology

Cellular biology

Biology

Collection
DCE Theses and Dissertations
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.